Xiongjie Yu

563 total citations
20 papers, 405 citations indexed

About

Xiongjie Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiongjie Yu has authored 20 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Xiongjie Yu's work include Coenzyme Q10 studies and effects (3 papers), Organic Chemistry Cycloaddition Reactions (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Xiongjie Yu is often cited by papers focused on Coenzyme Q10 studies and effects (3 papers), Organic Chemistry Cycloaddition Reactions (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Xiongjie Yu collaborates with scholars based in China, Hong Kong and Germany. Xiongjie Yu's co-authors include Xiaojun Cai, Fengjun Cao, Xuanbin Wang, Yuandong Yu, Fengjun Cao, Ping Chen, Linjun Li, Dongfeng Pan, Mingxing Li and Yong Li and has published in prestigious journals such as Journal of Clinical Oncology, Biochemical and Biophysical Research Communications and Clinica Chimica Acta.

In The Last Decade

Xiongjie Yu

19 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiongjie Yu China 9 215 120 72 72 46 20 405
Niloufar Mohammadkhani Iran 9 190 0.9× 100 0.8× 89 1.2× 66 0.9× 32 0.7× 11 467
Tseng‐Hsi Lin Taiwan 13 187 0.9× 82 0.7× 49 0.7× 58 0.8× 37 0.8× 19 480
Bing Dai China 9 293 1.4× 152 1.3× 83 1.2× 106 1.5× 21 0.5× 15 557
Hyeong Sim Choi South Korea 13 257 1.2× 110 0.9× 25 0.3× 78 1.1× 49 1.1× 20 421
Haydar Çelik United States 13 232 1.1× 79 0.7× 56 0.8× 48 0.7× 25 0.5× 27 447
Shi Dong China 12 207 1.0× 120 1.0× 63 0.9× 65 0.9× 22 0.5× 28 388
Ying-Ming Tsai Taiwan 10 176 0.8× 67 0.6× 46 0.6× 92 1.3× 25 0.5× 15 340
Zimam Mahmud Bangladesh 12 199 0.9× 82 0.7× 35 0.5× 58 0.8× 20 0.4× 38 420
Jin Su China 13 143 0.7× 61 0.5× 45 0.6× 43 0.6× 61 1.3× 39 417
Yun‐Suk Kwon South Korea 11 176 0.8× 88 0.7× 33 0.5× 51 0.7× 39 0.8× 30 328

Countries citing papers authored by Xiongjie Yu

Since Specialization
Citations

This map shows the geographic impact of Xiongjie Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiongjie Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiongjie Yu more than expected).

Fields of papers citing papers by Xiongjie Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiongjie Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiongjie Yu. The network helps show where Xiongjie Yu may publish in the future.

Co-authorship network of co-authors of Xiongjie Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiongjie Yu. A scholar is included among the top collaborators of Xiongjie Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiongjie Yu. Xiongjie Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qiuyu, Cheng Chang, Hisashi Tanigawa, et al.. (2025). Hierarchical Temporal Processing in the Primate Thalamocortical System: Insights from Nonlinguistic Structured Stimuli. Research. 8. 960–960.
2.
Li, Yanli, et al.. (2022). Monensin Inhibits Anaplastic Thyroid Cancer via Disrupting Mitochondrial Respirationand AMPK/mTOR Signaling. Anti-Cancer Agents in Medicinal Chemistry. 22(14). 2539–2547. 11 indexed citations
3.
Zhang, Li, Xiaojun Cai, Li Dong, et al.. (2022). Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down‐regulation of lncRNA MALAT1. The Kaohsiung Journal of Medical Sciences. 38(6). 585–593. 8 indexed citations
4.
5.
Liu, Kaiqi, Hongliang Li, Xiaojing Chen, et al.. (2021). Progress in clinical research on the integration of Chinese and Western medicines for treating primary liver cancer. Journal of Traditional Chinese Medical Sciences. 8(3). 173–185. 7 indexed citations
6.
Yu, Xiongjie, Fengjun Cao, Yuandong Yu, et al.. (2021). HNRNPL Is Identified and Validated as a Prognostic Biomarker Associated with Microsatellite Instability in Human Gastric Cancer. DNA and Cell Biology. 40(10). 1251–1260. 3 indexed citations
7.
Wang, Dongpeng, Xiongjie Yu, Fengjun Cao, et al.. (2021). Pharmacokinetics of Anthraquinones from Medicinal Plants. Frontiers in Pharmacology. 12. 638993–638993. 84 indexed citations
8.
Zhang, Li, Wei Zhang, Ying Song, et al.. (2021). Circ_0008673 regulates breast cancer malignancy by miR-153-3p/CFL2 axis. Archives of Gynecology and Obstetrics. 305(1). 223–232. 17 indexed citations
9.
10.
Li, Yong, Yingqiu Song, Pindong Li, et al.. (2020). Downregulation of RIG-I mediated by ITGB3/c-SRC/STAT3 signaling confers resistance to interferon-α-induced apoptosis in tumor-repopulating cells of melanoma. Journal for ImmunoTherapy of Cancer. 8(1). e000111–e000111. 26 indexed citations
11.
Cao, Fengjun, Mingxing Li, Pindong Li, et al.. (2018). Enhanced mitochondrial pyruvate transport elicits a robust ROS production to sensitize the antitumor efficacy of interferon-γ in colon cancer. Redox Biology. 20. 451–457. 19 indexed citations
12.
Li, Yong, Fengjun Cao, Mingxing Li, et al.. (2018). Hydroxychloroquine induced lung cancer suppression by enhancing chemo-sensitization and promoting the transition of M2-TAMs to M1-like macrophages. Journal of Experimental & Clinical Cancer Research. 37(1). 259–259. 82 indexed citations
13.
Lin, Tian, Yuandong Yu, Fang Li, et al.. (2017). Overexpression of Pofut1 and activated Notch1 may be associated with poor prognosis in breast cancer. Biochemical and Biophysical Research Communications. 491(1). 104–111. 32 indexed citations
14.
Yu, Xiongjie, et al.. (2016). Associations between FAS rs2234767 and FASL rs763110 polymorphisms and the risk of lung cancer: a meta-analysis of 39,736 subjects. OncoTargets and Therapy. 9. 2049–2049. 5 indexed citations
15.
Yu, Xiongjie, Ping Chen, Dongfeng Pan, et al.. (2016). Metformin therapy associated with survival benefit in lung cancer patients with diabetes. Oncotarget. 7(23). 35437–35445. 49 indexed citations
16.
Chen, Ping, Linjun Li, Xiongjie Yu, et al.. (2015). Elevated red cell distribution width contributes to a poor prognosis in patients with esophageal carcinoma. Clinica Chimica Acta. 452. 199–203. 37 indexed citations
17.
Chen, Ping, et al.. (2015). Cyclooxygenase-2 polymorphisms and bladder cancer risk: a meta-analysis based on case-control studies.. PubMed. 8(3). 3935–45. 5 indexed citations
18.
Yu, Xiongjie, et al.. (2007). Synthetic Studies on Coenzyme Q10. Part 3. Helvetica Chimica Acta. 90(5). 967–971. 1 indexed citations
19.
Chen, Fen‐Er, et al.. (2006). Synthetic Studies on Coenzyme Q10. Part 2. Helvetica Chimica Acta. 89(7). 1317–1321. 4 indexed citations
20.
Yu, Xiongjie, et al.. (2005). Synthetic Studies on Coenzyme Q10. Helvetica Chimica Acta. 88(10). 2575–2581. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Niloufar Mohammadkhani Breakdown of academic impact, for papers by Tseng‐Hsi Lin Breakdown of academic impact, for papers by Bing Dai Breakdown of academic impact, for papers by Hyeong Sim Choi Breakdown of academic impact, for papers by Haydar Çelik Breakdown of academic impact, for papers by Shi Dong Breakdown of academic impact, for papers by Ying-Ming Tsai Breakdown of academic impact, for papers by Zimam Mahmud Breakdown of academic impact, for papers by Jin Su Breakdown of academic impact, for papers by Yun‐Suk Kwon
Rankless by CCL
2026